-transparent.png){kind=logo}
The in vivo pharmacological activity of L-364,718, a new, potent peripheral cholecystokinin (CCK) antagonist, was characterized in several species using assay systems that measure various well known actions of CCK upon the gastrointestinal system. Administered p.o., L-364,178 was highly potent in antagonizing cholecystokinin octapeptide (CCK-8)-induced inhibition of gastric emptying in mice (ED50 = 38 micrograms/kg), rats (ED50 = 140 micrograms/kg) and dogs (ED50 = 91 micrograms/kg) as well as CCK-8-induced reduction in food consumption in rats (ED50 = 321 micrograms/kg). Administered i.v., L-364,718 effectively antagonized the contractile effects of CCK on the colon in rabbits (ED50 = 34 micrograms/kg) and the gallbladder in cats (ED50 = 210 micrograms/kg). Secretion of pancreatic protein and amylase elicited by CCK in cats was also antagonized by L-364,718 (ED50 less than 1.0 mg/kg i.v.). The CCK antagonism produced by L-364,718 in all species persisted for at least 2 to 5 hr. In the absence of exogenously administered CCK-8, L-364,718 per se had no effect in any of the assay systems studied, indicating a lack of CCK-like agonist properties. Specificity for CCK was demonstrated by the inability of L-364,718 (1.0-5.0 mg/kg) to antagonize either amino acid- or atropine-induced inhibition of gastric emptying in rats and dogs, respectively. L-364,718 also did not antagonize motilin-induced gallbladder contractions or secretin-induced pancreatic secretion in cats.(ABSTRACT TRUNCATED AT 250 WORDS)
V J Lotti, and
R G Pendleton, and
R J Gould, and
H M Hanson, and
R S Chang, and
B V Clineschmidt
September 1986,
Molecular pharmacology,
V J Lotti, and
R G Pendleton, and
R J Gould, and
H M Hanson, and
R S Chang, and
B V Clineschmidt
July 1992,
The Journal of pharmacology and experimental therapeutics,
V J Lotti, and
R G Pendleton, and
R J Gould, and
H M Hanson, and
R S Chang, and
B V Clineschmidt
August 1995,
Clinical and experimental hypertension (New York, N.Y. : 1993),
V J Lotti, and
R G Pendleton, and
R J Gould, and
H M Hanson, and
R S Chang, and
B V Clineschmidt
January 1994,
Annals of clinical and laboratory science,
V J Lotti, and
R G Pendleton, and
R J Gould, and
H M Hanson, and
R S Chang, and
B V Clineschmidt
October 1985,
Science (New York, N.Y.),
V J Lotti, and
R G Pendleton, and
R J Gould, and
H M Hanson, and
R S Chang, and
B V Clineschmidt
January 1991,
Experimental cell research,
V J Lotti, and
R G Pendleton, and
R J Gould, and
H M Hanson, and
R S Chang, and
B V Clineschmidt
July 1990,
Pancreas,
V J Lotti, and
R G Pendleton, and
R J Gould, and
H M Hanson, and
R S Chang, and
B V Clineschmidt
February 1988,
European journal of pharmacology,
V J Lotti, and
R G Pendleton, and
R J Gould, and
H M Hanson, and
R S Chang, and
B V Clineschmidt
May 2001,
American journal of physiology. Regulatory, integrative and comparative physiology,
V J Lotti, and
R G Pendleton, and
R J Gould, and
H M Hanson, and
R S Chang, and
B V Clineschmidt
December 1996,
International journal of pancreatology : official journal of the International Association of Pancreatology,
